Abstract
Introduction ad libitum, were used for a diabetes model. Type-2 diabetes was induced in the mice with a single intraperitoneal (i.p.) injection of streptozotocin (STZ, 75 mg/kg of body weight) (Chem Cruz Biochemicals), freshly dissolved in 10 mM citrate buffer (pH 4.5) [1] . To confirm diabetes development, defined by a fasting blood glucose level higher than 250 mg/dl in 2 consecutive weeks (Glucometer Elite XL; Bayer Corp., Elkhart, IN) from the STZ injection, blood glucose levels were then monitored intermittently over a 10 week period from the initial diabetes assessment, a time frame necessary to the development of retinal alterations leading to diabetic retinopathy [1] .
C57BL6J mice (N = 10 per group) were randomized into the following experimental groups: (1) nondiabetic mice (CTRL group), receiving an injection of 10 mM citrate buffer alone; (2) nondiabetic mice receiving twice a week i.p. injection of 25 mg/kg BHB (Sigma, Italy) (CTRL+BHB 25 group); (3) nondiabetic mice receiving twice a week i.p. injection of 50 mg/kg BHB (CTRL+BHB 50 group); (4) nondiabetic mice receiving twice a week i.p. injection of 100 mg/kg BHB (CTRL+BHB 100 group); (5) diabetic mice (STZ group); (6) diabetic mice treated twice a week with i.p. injection of 25 mg/kg BHB (STZ+BHB 25 group); (7) diabetic mice treated twice a week with i.p. injection of 50 mg/kg BHB (STZ+BHB 50 group); (8) diabetic mice treated twice a week with i.p. injection of 100 mg/kg BHB (STZ+BHB 100 group) [27] . All the BHB administrations did not modify the blood pH values. At the end of the 10-week period, blood samples were taken from the tail vein (0.2-0.25 ml) into a heparinized Eppendorf vial [28] . A fraction of the whole blood was used for at room temperature for 30 minutes, was centrifuged at 3000 g for 10 minutes at 4˚C to obtain serum, which was collected as supernatant fractions [29] . BHB serum levels were checked at the end of 10 weeks by using the β-Hydroxybutyrate ELISA Kit (ABIN773249 Biocompare, Italy), according the manufacturer's protocol. The mice were then sacrificed, and the retina was dissected as previously described [1] . Retinal samples were then prepared for the Tunel assay, immunofluorescence or biochemical analysis. This study was carried out according to the recommendations of the National Sanitary Veterinary and Food Safety Authority of Romania. The experimental protocol was approved by the Institutional Ethical Committee for Research of the "Vasile Goldis" Western University of Arad (number 29/17.05.2017), and all efforts were made to minimize animal suffering and the number of animals used.
In situ detection of DNA fragmentation
TdT-FragEL DNA Fragmentation Detection Kit (Calbiochem, EMD Chemicals, INC, San Diego, USA) was used to assess in situ nuclear DNA fragmentation based on terminal deoxynucleotidyl transferase (TdT), according to the manufacturer's protocol. The insertion of biotinylated nucleotides allows chromosomal DNA fragmentation to be visualized with streptavidin-horseradish peroxidase (HRP), and stained with diaminobenzidine (DAB), which generates an insoluble dark brown substrate at the site of DNA fragmentation. Nuclear counterstaining was performed with methyl green solution, included in the kit. Sections were viewed by light microscopy (Olympus BX43, Japan) and digital pictures were analyzed with ImageJ software version 1.4. The apoptotic index was expressed as the percentage of TUNEL + nuclei versus the total number of nuclei previously counterstained with methyl green.
Immunofluorescence
The paraffin embedded retina sections were deparaffinized and rehydrated in an alcohol gradient (100%, 96% and 70% volume). The sections were washed, and antigen unmasking was performed with sodium citrate buffer (pH 6.0). Slides were blocked with 1% bovine serum albumin (BSA) and 5% normal goat serum in phosphate buffered saline (PBS) solution, washed with PBS and incubated with primary antibody, connexin 43 (sc-59949 Santa Cruz, US), for 2 h at 1:200 dilution. The slides were washed and then incubated with the corresponding secondary antibodies diluted 1:500 (Alexa Fluor dye conjugated) in the appropriate blocking solution for 1 h at room temperature in the dark. Counterstaining of nuclei was performed with DAPI. Stained slides were mounted in fluorescence mounting medium (Sigma Chemical, Italy) and analyzed under a Leica TCS SP8 confocal microscope. The intensity of the connexin 43 fluorescence was analyzed with ImageJ64 software (NIH, Bethesda, Maryland, USA). Five fields were selected randomly from each retina section. These values are presented as percentage fluorescence compared to the control group, which is set at 100%.
Protein quantitation of retinal samples
Following removal of the retinal samples from the C57BL6J mice, they were immediately frozen in liquid nitrogen and stored at -80˚C for the subsequent protein collection. Tissue homogenization was performed in RIPA buffer (R0278 Sigma-Aldrich, USA) supplemented with a protease inhibitor cocktail (11873580001 Roche, USA). Then, to remove any nucleic acid contaminants, tissue lysates were centrifuged at 12,000 rpm for 10 min at 4˚C, and the supernatants were collected [30] . The protein content of the supernates, used for ELISA and Western Blotting assays, was determined according the Bio-Rad protein assay (500-0006 BioRad Laboratories, Italy).
Western blotting assay
Proteins were separated on a 12% PAGE separation gel and then electrotransferred onto a PVDF membrane (IPFL10100 Merck Millipore, Italy). The membrane was blocked for 1 hour at room-temperature with 5% nonfat dry milk and then incubated overnight with the following primary specific antibodies: anti-actin (sc-8432 Santa Cruz, USA), anti-HCA 2 (A02511 BosterBio, USA), anti-eukaryotic translation initiation factor 2-α kinase (PERK) (sc377400Santa Cruz, USA), anti-phospho-PERK (pPERK) (sc-32557 Santa Cruz, USA), antiinositol requiring enzyme 1 (IRE1) (ab37073abcam, Italy) and anti-phospho-IRE1 (pIRE1) (PA1-16927 ThermoFisher, Italy). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit (1:5000 ADI-SAB-300) and anti-mouse (1:5000 ADISAB-110 Enzo, Italy) were used as secondary antibodies and incubated for 1 hour at room temperature. The chemiluminescent signals were revealed and expressed as Densitometric Units (D.U.).
ELISA tests
Retinal BHB levels were determined using the β-Hydroxybutyrate ELISA Kit (ABIN773249 Biocompare, Italy), following the manufacturer's instructions. Retinal membrane-anchored transcription factor 6α (ATF-6α) (LS-F9075 LifeSpan BioSciences, Italy), NLRP3 (MBS920134 MyBioSource, USA), apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) (MBS733407 MyBioSource, USA), caspase-1 (MBS092313 MyBioSource, USA), Interleukin 1β (IL-1β) (SMLB00C R&D System, USA) and Interleukin-18 (IL-18) (ab216165 Abcam, Italy) levels were detected using specific ELISA assays, according to the manufacturer's protocols.
Statistical analysis
All values from the in vivo experiments are expressed as the mean ± standard error of the mean (S.E.M.) of N = 10 mice. Statistical significance was assessed by Student's t-test comparing two experimental groups or one-way analyses of variance (ANOVA), followed by Dunnett's post hoc test (more than two experimental groups). To reject the null hypothesis, a P-value less than 0.05 was considered significant.
Results

Retinal HCA 2 receptor protein expression and BHB levels in diabetic mice
Western blot analysis showed that STZ mice exhibited significantly increased HCA 2 receptor protein expression (P < 0.01 vs CTRL) compared to CTRL group (Fig 1A) . Elevated HCA 2 receptor protein expression was also detectable in diabetic mice treated with BHB 25-50-100 mg/kg (P < 0.01 vs CTRL) ( Fig 1A) . As expected, STZ mice had serum BHB levels similar to those of CTRL mice, while mice receiving 50 mg/kg and 100 mg/kg BHB both in CTRL and STZ groups exhibited a significant increase in BHB serum levels (P < 0.01 vs CTRL) (Fig 1B) . Moreover, STZ mice showed retinal BHB levels similar to CTRL group (Fig 1C) . These were significantly increased in nondiabetic mice receiving 50 mg/kg (P < 0.05 vs CTRL) and 100 mg/kg BHB (P < 0.01 vs CTRL), as well as in STZ mice administered with 50 mg/kg and 100 mg/kg BHB (respectively P < 0.05 and P < 0.01 vs STZ) (Fig 1C) . In particular, diabetic mice receiving the three different BHB doses showed significantly increased retinal BHB levels compared to the nondiabetic mice receiving the same BHB dose (P < 0.05 vs CTRL+BHB at the same dose) (Fig 1C) 
Retinal apoptosis and connexin 43 expression in diabetic mice treated with BHB
The elevation of the expression of HCA 2 in the retina of diabetic mice was accompanied by a decrease of the expression of the tight junction marker connexin 43 with respect to the nondiabetic mice (P < 0.01 vs CTRL). This was accompanied by an increase in apoptotic cell number compared to the control group (P < 0.01 vs CTRL). Administration of 50 mg/kg and 100 mg/ kg BHB in diabetic mice, thereby activating local HCA 2 , dose-dependently increased the content of connexin 43 in the outer nuclear layer (ONL) (P < 0.01 vs STZ) and reduced apoptotic cells (respectively P < 0.05 and P < 0.01 vs STZ), which underlie the decrease in retinal damage (Fig 2) .
Retinal ER stress markers and BHB treatment in diabetic mice
Data from Western Blot and ELISA assays showed that the retinas of diabetic mice (STZ group) exhibited significantly elevated levels of the ER stress markers pPERK, pIRE1 and ATF-6α compared to the retinas of nondiabetic mice (CTRL group) (P <0.01 vs CTRL) (Fig  3) . In the retinas of diabetic mice receiving systemic injections of 50 mg/kg and 100 mg/kg BHB (STZ+BHB groups), the ER stress markers were significantly decreased (respectively, P < 0.05 and P < 0.01 vs STZ) compared to the STZ group (Fig 3) .
BHB reduces retinal NLRP3 inflammasome activation markers in diabetic mice
The elevated ER stress markers in diabetic mice (STZ group) were accompanied by significantly increased levels of NLRP3 inflammasome activation markers, such as NLRP3, ASC and caspase-1 (P < 0.01 vs CTRL) (Fig 4) . In addition, the levels of the proinflammatory cytokines IL-1β and IL-18, which are closely related to NLRP3 inflammasome activity, were significantly increased in STZ mice compared to the nondiabetic group (P < 0.01 vs CTRL) (Fig 5) . Of note, BHB treatment of the diabetic mice with 50 and 100 mg/kg doses (STZ+BHB group) significantly reduced the NLRP3 inflammasome activation markers previously described (respectively, P < 0.05 and P < 0.01 vs STZ) (Fig 4) , together with a reduction of IL-1β and IL-18 levels (respectively, P < 0.05 and P < 0.01 vs STZ) (Fig 5) .
Discussion
The present study shows that the systemic injection of BHB to STZ-C57Bl6J mice results in retinal protection from diabetic damage through the local activation of the hydroxycarboxylic acid receptor 2, reduction of the ER stress-induced NLRP3 inflammasome activation and a decrease in retinal outer nuclear layer cell death.
HCA 2 or GPR109A, formerly known as HM74A in humans and PUMA-G (Protein Upregulated in Macrophages by Interferon-γ) in rodents [31] , is a G i -protein-coupled receptor recognized as an important drug target for treating inflammatory processes [32] . It is endogenously activated by β-hydroxybutyrate (BHB), a ketone body that also exerts an Local HCA2 receptor activation by beta-hydroxybutyrate reduces NLRP3 inflammasome in diabetic retinal damage interesting protective effect in different experimental models of neuropathic pain [33] . HCA 2 receptor is constitutively expressed in all the retinal layers, including retinal pigment epithelial (RPE) cells [4, 5, 34] . These cells play a critical role in the modulation of the immune and inflammatory responses in retinal physiological conditions, particularly diabetic retinopathy [35] [36] [37] [38] . In this context, the present study shows that the HCA 2 receptor is overexpressed in the retinas of diabetic mice compared to nondiabetic mice. In addition, this HCA 2 overexpression is accompanied by retinal endogenous BHB levels comparable to that of the nondiabetic mice, data herein described for the first time. In fact, previous studies by Gambhir and colleagues [5] quantified the levels of circulating BHB, without accompanying information on retinal levels. Moreover, the current results reveal that the levels of retinal endogenous BHB in diabetic mice are insufficient to fully activate local overexpressed HCA 2 receptors, thus expressing the protective effects. Insufficient HCA 2 stimulation resulted in clear retinal damage in the diabetic animals in our setting. Overall, BHB and HCA 2 activation are in a very delicate balance, since high BHB levels (>1.8 mmol/L) are largely detrimental and do not optimally activate HCA 2 receptors [4, 39] ; conversely, low BHB levels, as in well-controlled diabetes, also do not activate HCA 2 [40] . Therefore, a strategic increase in BHB bioavailability and proper activation of HCA 2 might counteract diabetic retinal damage. As such, we illustrate here that a systemic administration of BHB can increase both serum and retinal BHB levels in nondiabetic and diabetic mice. Particularly, in the latter mice, the retinal BHB enhancement was twice that of the nondiabetic animals. Since we used STZ-C57BL6J mice as a model of diabetic retinal damage without BHB serum elevation [5, 41, 42] , it was assumed that the BHB found in the retina was partially derived from the exogenous BHB through systemic circulation. Although an increase in the retina was expected in the nondiabetic mice, since the ketone body 3-hydroxybutyrate is transported across the blood retinal barrier into the eye [43] , the elevation of retinal BHB from exogenous intraperitoneal application represents a novelty in diabetic mice. In the experimental groups, BHB reached significantly higher retinal levels than in the nondiabetic group, likely because it much more easily crossed the retinal blood barrier due to the increased permeability of the damaged barrier in diabetics [44] . This was indicated by a decreased expression of the gap junction integrity marker connexin 43 (Cnx43) in the outer nuclear layer (ONL) of the diabetic retina, paralleled Local HCA2 receptor activation by beta-hydroxybutyrate reduces NLRP3 inflammasome in diabetic retinal damage by a higher number of ONL apoptotic cells. Cnx43 plays an important role in maintaining cell survival, since it favors gap junction integrity, thus permitting communication between several cell types, such as endothelial cells, pericytes and retinal Müller cells [45] [46] [47] . Of note, the inhibition of retinal Cnx43 expression induced by high glucose levels increases retinal cell Local HCA2 receptor activation by beta-hydroxybutyrate reduces NLRP3 inflammasome in diabetic retinal damage apoptosis and derangement in diabetics [1, 48, 49] . These data are supported by several studies in different experimental settings, showing that reduced Cnx43 expression resulted in increased apoptosis in rat ventricular myocytes [50] and Cnx43-null mice exhibited increased programmed cell death [51] . Interestingly, the diabetic mice treated with BHB exhibited a Local HCA2 receptor activation by beta-hydroxybutyrate reduces NLRP3 inflammasome in diabetic retinal damage reduced degree of ONL apoptosis paralleled by a slight restoration of Cnx43 expression, suggesting a protective role of the properly activated HCA 2 against retinal derangement. To explain how the activation of HCA 2 by local BHB exerts retinal protection from the mechanistic point of view, we report that diabetic retinas develop elevated endoplasmic reticulum (ER) stress, manifested here by the increased levels of the ER stress markers phosphorylated proteinkinase (PKR)-like endoplasmic reticulum kinase (pPERK), phosphorylated endoplasmic reticulum to nucleus signaling 1 (pIRE1) and protein ATF-6α [20] in the retina. These proteins are resident transmembrane proteins bound to the ER and are increased following high stress signals to the ER [52] in order to retro-translocate misfolded proteins into the cytoplasm and save the ER from damage through an unfolded protein response [53] . Exogenous BHB reduced the expression levels of all in proteins into the retina, suggesting a reduction in ER stress.
Although a reduction of ER stress through pharmacological activation of HCA 2 by BHB can save cells and tissue from derangements per sè [53] , it is our opinion that BHB, through HCA 2 activation, may also influence other downstream events or factors that produce the cellular damage in the retina of diabetics. BHB also emerged as an NLRP3 inflammasome inhibitor in several experimental settings [17] [18] [19] [20] [21] [22] [23] where the ER stress is the initiator. NLRP3 is a multiprotein complex composed of the sensor protein NLRP3, the apoptosis-associated specklike protein containing a caspase-1 recruitment domain (ASC) and caspase-1 [54] [55] [56] . With diabetes, NLRP3 is stimulated by the ER stress and cleaves and stimulates caspase-1, leading to secretion and release of the pro-inflammatory cytokines IL-1β and IL-18 [57] . Altogether, these factors lead to cell and tissue damage. Here, the level of retinal damage in the diabetic mice was paralleled by high levels of NLRP3 inflammasome activation markers, such as NLRP3 protein, ASC and caspase-1, and by elevated levels of IL-1β and IL-18 secreted following NLRP3 inflammasome activation, all of which were reduced by systemic BHB application. These results support several studies showing that NLRP3 inflammasome activation is mediated by ER stress and is negatively involved in retinal damage induced by diabetes [56, [58] [59] [60] [61] [62] [63] [64] [65] . Although we cannot distinguish between a direct inhibition of NLRP3 and an ER-dependent inhibition by systemic BHB, we can tentatively assume that a positive circuit involving HCA 2 -ER stress and NLRP3 exists in the retina, thereby controlling the diabetic retinal outcome.
In summary, the present study shows i) overexpression of retinal HCA 2 with diabetes; ii) increased levels of retinal BHB after systemic administration; iii) reduced ER stress after BHB; iv) reduced NLRP3 inflammasome activity after BHB; and finally, v) reduced retinal damage (Fig 6) . These findings pave the way for future investigations on the possible effects of BHB on retinal microglia ramifications, polarization and phagocytosis since BHB has been found to modulate microglia phenotypes associated with the neuro-inflammatory processes underlying retinal degeneration [66] . However, the present data from our experimental setting consistently support the hypothesis that HCA 2 involvement in the pathogenesis of diabetic retinopathy and its pharmacological activation may offer a new therapeutic target for modulating the inflammatory processes underlying diabetic retinal damage.
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